Li An1, Shizhe Li1, Maria Ferraris Araneta1, Milalynn Victorino1, Christopher Johnson1, and Jun Shen1
1National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
Synopsis
A recently developed
single-step spectral editing 1H MRS technique that induces
intense Glu and Gln H4 singlets at TE = 56 ms was used to measure fractional
enrichments of glutamate and glutamine in the dorsal anterior cingulate
cortex (dACC) of five healthy volunteers after
oral administration of [U-13C]glucose. This technique offers the ability to measure
glutamate neurotransmission in the human brain with the high sensitivity and
spatial resolution of 1H MRS using standard commercial equipment.
INTRODUCTION
Noninvasive in vivo
detection of 13C labeling of glutamate (Glu) and glutamine (Gln) is a powerful tool for investigating Glu
and Gln metabolism and neurotransmission in the brain 1. Attempts
have been made to circumvent the hardware limitation of 13C MRS by
measuring the changes in short TE 1H MRS spectra caused by
incorporation of 13C labels into brain amino acids 2.
However, it has been difficult to reliably separate Glu and Gln in
the crowded 1H MRS spectra, especially after the incorporation of 13C
labels. Quantification of 13C labeling of both Glu and Gln using 1H
MRS in the human brain has not been reported. In this work, we demonstrate the
feasibility of measuring 13C fractional enrichments of Glu and Gln at
7 T using a recently published single-step spectral editing 1H MRS pulse
sequence, which induces
intense Glu and Gln H4 singlets at TE = 56 ms using an always-on editing pulse
at 2.12 ppm 3. METHODS
Five healthy volunteers were
scanned on a Siemens Magnetom 7 T scanner equipped with a 32-channel receiver
head coil. In each scan session, the subject was first scanned to acquire the
pre-13C MRS data from a 3.5 × 1.8 × 2 cm3 voxel in the dorsal anterior cingulate cortex (dACC) of the brain. Subsequently, the subject exited from the scanner and was orally administered 20% w/w 99% enriched [U-13C]glucose solution at a dosage of 0.75 g
[U-13C]glucose per kg of body
weight. After a rest period, the subject reentered the scanner. Post-13C MRS data were
repeatedly acquired from the same voxel as the pre-13C scan.
The pre-13C MRS data were processed first and the process was similar to
that described previously 3. Using an in-house
developed fitting program, the reconstructed pre-13C spectrum was
fitted in the range of 1.8 – 3.4 ppm by linear combination of numerically computed
basis spectra of acetate (Ace), N-acetyl-aspartate (NAA),
N-acetylaspartylglutamate (NAAG), γ-aminobutyric
acid (GABA),
Glu, Gln, glutathione (GSH), aspartate (Asp), total creatine (tCr), total
choline (tCho), taurine (Tau), myo-inositol (mI), and scyllo-inositol (sI), as well as a cubic spline baseline with 13 knots. After the metabolite concentrations in arbitrary unit were obtained from
the fitting, we computed the metabolite ratios, which were defined as the
concentration of a metabolite divided by the sum of concentration of tCr and three times the concentration of tCho ([tCr]+3[tCho]), which weighs
approximately equally the intensities of the tCr and tCho singlet peaks.
The post-13C
spectra were reconstructed in the same way as the pre-13C spectrum. Additional
basis spectra of 13C satellites of Glu H4, Gln H4 and Asp
H3 were simulated for the subsequent fitting process. When fitting each post-13C
spectrum, the metabolites ratios (/ [tCr]+3[tCho]) of Ace, NAA, NAAG, GABA,
GSH, Asp, tCr, tCho, Tau, mI, and sI were fixed to the pre-13C
values. The sum of metabolite
ratios of Glu and its 13C satellites was constrained to be the same as the metabolite
ratio of Glu obtained from the pre-13C spectrum. Similar constraints were also applied to Gln and Asp. After obtaining the
metabolite concentrations from the fitting process, the 13C fractional enrichment of Glu H4 for a post-13C spectrum was computed as the ratio of the
concentration of its 13C satellites to the total concentration of Glu. The
fractional enrichment of Gln H4 was similarly computed.RESULTS
Figure
1 shows the basis spectra of Glu, Gln, Asp, and their 13C satellites.
The spectrum of [4,5-13C]Glu is highly similar to that of [4-13C]Glu
because the spectral pattern is dominated by the large 1JHC.
As both carbons of the acetyl
CoA are 13C-labeled after administration of uniformly labeled
glucose 4, [4,5-13C]Glu was chosen to represent
the 13C satellite signals of Glu H4 in the fitting process. Similarly,
[4,5-13C]Gln and [3,4-13C]Asp were chosen to represent
the 13C satellite signals of Gln H4 and Asp H3, respectively. Figure 2 displays
the time-course spectra of subject 1 and corresponding fitted spectra of Glu, Gln and their 13C
satellites. The in vivo spectra and corresponding fits for
the pre-13C MRS scan and the last post-13C scan of
subject 1 are displayed in Figure 3. The plots of fractional enrichments of Glu H4 and Gln H4 vs. time after oral administration of [U-13C]glucose
for all five subjects are displayed in Figure 4. Table 1 lists the metabolite
ratios (/[tCr]) and end point fractional enrichments of Glu H4 and Gln H4 in the
dACC of all
five subjects. DISCUSSION AND CONCLUSION
We demonstrated the feasibility of using a proton-only
single-step spectral editing sequence with TE = 56 ms to measure fractional
enrichments of Glu and Gln in the dACC of healthy volunteers after oral
administration of [U-13C]glucose. Compared to the existing indirect 1H-[13C]
MRS techniques that use 1H and 13C surface coils, this 1H
MRS technique can acquire MRS data from a voxel away from the neocortex using a
standard 1H head coil. This
technique offers the ability to measure glutamate neurotransmission in the
human brain with the high sensitivity and spatial resolution of 1H
MRS using standard commercial equipment. Brain regions inaccessible to surface
coils can now be investigated using the technique described in this work. Acknowledgements
This work was supported by the intramural
program of the NIH and NIMH. References
- Rothman
DL, de Graaf RA, Hyder F, Mason GF, Behar KL, De Feyter HM. In vivo 13C and 1H-[13C] MRS studies of neuroenergetics and neurotransmitter cycling,
applications to neurological and psychiatric disease and brain cancer. NMR
Biomed 2019;32(10):e4172.
- Boumezbeur F, Besret L,
Valette J, Vaufrey F, Henry PG, Slavov V, Giacomini E, Hantraye P, Bloch G,
Lebon V. NMR measurement of brain oxidative metabolism in monkeys using
C-13-labeled glucose without a C-13 radiofrequency channel. Magnetic Resonance
in Medicine 2004;52(1):33-40.
- An L, Araneta MF, Victorino
M, Shen J. Signal enhancement of glutamine and glutathione by single-step
spectral editing. Journal of Magnetic Resonance 2020;316.
- Li SZ, Zhang Y, Araneta MF, Xiang Y, Johnson
C, Innis RB, Shen J. In vivo detection of C-13 isotopomer turnover in the human
brain by sequential infusion of C-13 labeled substrates. Journal of Magnetic
Resonance 2012;218:16-21.